SKC-11713-53423
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 783 / TX
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-18
-
2021-01-26
Dose 2 — Moderna
- 2021-03-29
-
2021-06-28
Survey response — 6 months, dose 1MedDRA: Dyspnoea, Palpitations — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shortness of breath and frequent palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-30
- 2021-07-06
-
2021-10-14
Dose 3 — Moderna
- 2021-12-28
- 2022-01-13
- 2022-04-14
-
2022-10-16
Survey response — 12 months, dose 3MedDRA: Hypertension, Hyperthyroidism — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hyperthyroidism and hypertensionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-26 | Moderna | No |
| 3 | 2021-10-14 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — 6 months, dose 1
Symptoms: Shortness of breath and frequent palpitations
Release 12 — 12 months, dose 3
Symptoms: Hyperthyroidism and hypertension
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Hyperthyroidism | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release